ArticleInternational journal of organ transplantation medicine2013

Pharmacovigilance Analysis of Serious Adverse Events Reported for Biologic Response Modifiers Used as Prophylaxis against Transplant Rejection: a Real-World Postmarketing Experience from the US FDA Adverse Event Reporting System (FAERS).

A K AliPubMed ↗Full text ↗

No numbers read from the abstract.